Maternal fibrinogen/fibrin degradation products to high density lipoprotein cholesterol ratio for predicting delivery of small and large for gestational age infants: a pilot study.
Birthweight
FDP
FHR
HDL-C
LGA
Prediction
SGA
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
12 Dec 2023
12 Dec 2023
Historique:
received:
19
05
2023
accepted:
06
12
2023
medline:
13
12
2023
pubmed:
13
12
2023
entrez:
13
12
2023
Statut:
epublish
Résumé
The purpose of this pilot study was to investigate associations between fibrinogen/fibrin degradation products (FDP) to high density lipoprotein-cholesterol (HDL-C) ratio (FHR) of mothers and the risk of delivering large/small for gestational age (LGA/SGA) infants and to evaluate the predictive power of FHR on LGA/SGA. This study retrospectively reviewed 11,657 consecutive women whose lipid profiles and FDP levels were investigated at the time of admission for delivery at a specialized hospital. The FHR was calculated, and perinatal outcomes, including clinical parameters, were analyzed. The prevalence of SGA was 9% (n = 1034), and that of LGA was 15% (n = 1806) in this cohort study. FHR was significantly lower in women who delivered SGA infants (4.0 ± 3.2 vs. 4.7 ± 3.3 mg/mmol, P < 0.01) and higher in women who delivered LGA infants (5.7 ± 3.8 vs. 4.7 ± 3.3 mg/mmol, P < 0.01) compared with those who delivered infants of normal size for their gestational age. Women in the top quartile for FHR (> 5.9 mg/mmol) had a 2.9-fold higher risk of delivering LGA infants [adjusted odds ratio (OR) = 2.9, P < 0.01] and a 47% lower risk of delivering SGA infants (adjusted OR = 0.47, P < 0.01) than those in the bottom quartile (< 2.7 mg/mmol). In addition, adding FHR to the conventional models significantly improved the area under the curve for the prediction of delivering LGA (0.725 vs. 0.739, P < 0.01) and SGA (0.717 vs. 0.727, P < 0.01) infants. These findings suggest that the FHR calculated in late pregnancy is an innovative predictor of delivering LGA and SGA infants. Combining FHR with perinatal parameters could thus enhance the predictive ability for predicting the delivery of LGA/SGA infants.
Sections du résumé
BACKGROUND
BACKGROUND
The purpose of this pilot study was to investigate associations between fibrinogen/fibrin degradation products (FDP) to high density lipoprotein-cholesterol (HDL-C) ratio (FHR) of mothers and the risk of delivering large/small for gestational age (LGA/SGA) infants and to evaluate the predictive power of FHR on LGA/SGA.
METHODS
METHODS
This study retrospectively reviewed 11,657 consecutive women whose lipid profiles and FDP levels were investigated at the time of admission for delivery at a specialized hospital. The FHR was calculated, and perinatal outcomes, including clinical parameters, were analyzed.
RESULTS
RESULTS
The prevalence of SGA was 9% (n = 1034), and that of LGA was 15% (n = 1806) in this cohort study. FHR was significantly lower in women who delivered SGA infants (4.0 ± 3.2 vs. 4.7 ± 3.3 mg/mmol, P < 0.01) and higher in women who delivered LGA infants (5.7 ± 3.8 vs. 4.7 ± 3.3 mg/mmol, P < 0.01) compared with those who delivered infants of normal size for their gestational age. Women in the top quartile for FHR (> 5.9 mg/mmol) had a 2.9-fold higher risk of delivering LGA infants [adjusted odds ratio (OR) = 2.9, P < 0.01] and a 47% lower risk of delivering SGA infants (adjusted OR = 0.47, P < 0.01) than those in the bottom quartile (< 2.7 mg/mmol). In addition, adding FHR to the conventional models significantly improved the area under the curve for the prediction of delivering LGA (0.725 vs. 0.739, P < 0.01) and SGA (0.717 vs. 0.727, P < 0.01) infants.
CONCLUSION
CONCLUSIONS
These findings suggest that the FHR calculated in late pregnancy is an innovative predictor of delivering LGA and SGA infants. Combining FHR with perinatal parameters could thus enhance the predictive ability for predicting the delivery of LGA/SGA infants.
Identifiants
pubmed: 38087267
doi: 10.1186/s12944-023-01986-x
pii: 10.1186/s12944-023-01986-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
221Subventions
Organisme : Natural Science Research Project of Anhui Educational Committee
ID : KJ2021A1200
Organisme : Changzhou Medical Center of Nanjing Medical University
ID : CMCC202219
Organisme : Jiangsu Maternal and Child Health Research Projects
ID : F201842
Organisme : Changzhou science and technology infrastructure construction project
ID : Key Laboratory, CM20223012
Informations de copyright
© 2023. The Author(s).
Références
Briana DD, Malamitsi–Puchner A. Developmental origins of adult health and Disease: the metabolic role of BDNF from early life to adulthood. Metabolism. 2018;81:45–51.
doi: 10.1016/j.metabol.2017.11.019
pubmed: 29217485
Ding G, Tian Y, Zhang Y, Pang Y, Zhang JS, Zhang J. Application of a global reference for fetal-weight and birthweight percentiles in predicting infant mortality. BJOG. 2013;120:1613–21.
doi: 10.1111/1471-0528.12381
pubmed: 23859064
Mericq V, Martinez-Aguayo A, Uauy R, Iñiguez G, Van der Steen M, Hokken-Koelega A. Long-term metabolic risk among children born premature or small for gestational age. Nat Rev Endocrinol. 2017;13:50–62.
doi: 10.1038/nrendo.2016.127
pubmed: 27539244
Viswanathan S, McNelis K, Makker K, Calhoun D, Woo JG, Balagopal B. Childhood obesity and adverse cardiometabolic risk in large for gestational age infants and potential early preventive strategies: a narrative review. Pediatr Res. 2022;92:653–61.
doi: 10.1038/s41390-021-01904-w
pubmed: 34916624
Lee AC, Kozuki N, Cousens S, Stevens GA, Blencowe H, Silveira MF, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 2017;358:j3677.
doi: 10.1136/bmj.j3677
pubmed: 28819030
pmcid: 5558898
Jones-Smith JC, Dow WH, Oddo VM. Association between native American-owned casinos and the prevalence of large-for-gestational-age births. Int J Epidemiol. 2017;46:1202–10.
doi: 10.1093/ije/dyx054
pubmed: 28430971
pmcid: 5837659
Yuan X, Han X, Zhou W, Long W, Wang H, Yu B, et al. Association of folate and vitamin B12 imbalance with adverse pregnancy outcomes among 11,549 pregnant women: an observational cohort study. Front Nutr. 2022;9:947118.
doi: 10.3389/fnut.2022.947118
pubmed: 35958250
pmcid: 9358651
Nahavandi S, Seah JM, Shub A, Houlihan C, Ekinci EI. Biomarkers for Macrosomia Prediction in pregnancies affected by Diabetes. Front Endocrinol (Lausanne). 2018;9:407.
doi: 10.3389/fendo.2018.00407
pubmed: 30108547
Yuan X, Gao Y, Zhang M, Long W, Liu J, Wang H, et al. Association of maternal D-dimer level in late pregnancy with birth outcomes in a Chinese cohort. Clin Chim Acta. 2020;501:258–63.
doi: 10.1016/j.cca.2019.10.048
pubmed: 31730819
Wang D, Xu S, Chen H, Zhong L, Wang Z. The associations between triglyceride to high-density lipoprotein cholesterol ratios and the risks of gestational Diabetes Mellitus and large-for-gestational-age infant. Clin Endocrinol (Oxf). 2015;83:490–7.
doi: 10.1111/cen.12742
pubmed: 25665068
Ye K, Bo QL, Du QJ, Zhang D, Shen Y, Han YP, et al. Maternal serum lipid levels during late pregnancy and neonatal body size. Asia Pac J Clin Nutr. 2015;24:138–43.
pubmed: 25740752
Jin WY, Lin SL, Hou RL, Chen XY, Han T, Jin Y, et al. Associations between maternal lipid profile and pregnancy Complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16:60.
doi: 10.1186/s12884-016-0852-9
pubmed: 27000102
pmcid: 4802610
Wang H, Dang Q, Zhu H, Liang N, Le Z, Huang D, et al. Associations between maternal serum HDL-c concentrations during pregnancy and neonatal birth weight: a population-based cohort study. Lipids Health Dis. 2020;19:93.
doi: 10.1186/s12944-020-01264-0
pubmed: 32410711
Xi F, Chen H, Chen Q, Chen D, Chen Y, Sagnelli M, et al. Second-trimester and third-trimester maternal lipid profiles significantly correlated to LGA and macrosomia. Arch Gynecol Obstet. 2021;304:885–94.
doi: 10.1007/s00404-021-06010-0
pubmed: 33651156
Parlakgumus HA, Aytac PC, Kalaycı H, Tarim E. First trimester maternal lipid levels and serum markers of small- and large-for-gestational age infants. J Matern Fetal Neonatal Med. 2014;27:48–51.
doi: 10.3109/14767058.2013.799658
pubmed: 23617575
Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, et al. Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational Diabetes Mellitus. CMAJ. 2012;184:1353–60.
doi: 10.1503/cmaj.111154
pubmed: 22619341
pmcid: 3447046
Adelborg K, Larsen JB, Hvas AM. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br J Haematol. 2021;192:803–18.
doi: 10.1111/bjh.17172
pubmed: 33555051
Wang T, Kang X, He L, Liu Z, Xu H, Zhao A. Prediction of thrombophilia in patients with unexplained recurrent pregnancy loss using a statistical model. Int J Gynaecol Obstet. 2017;138:283–7.
doi: 10.1002/ijgo.12213
pubmed: 28504829
Yuan X, Gao Y, Zhang M, Long W, Liu J, Wang H, et al. Fibrin/fibrinogen degradation products in late pregnancy promote macrosomia prediction in normal uncomplicated pregnancy. Placenta. 2020;96:27–33.
doi: 10.1016/j.placenta.2020.04.011
pubmed: 32560855
Wang W, Long K, Deng F, Ye W, Zhang P, Chen X, et al. Changes in levels of coagulation parameters in different trimesters among Chinese pregnant women. J Clin Lab Anal. 2021;35(4):e23724.
doi: 10.1002/jcla.23724
pubmed: 33543804
pmcid: 8059730
Dockree S, Brook J, James T, Shine B, Impey L, Vatish M. Pregnancy-specific reference intervals for C-reactive protein improve diagnostic accuracy for Infection: a longitudinal study. Clin Chim Acta. 2021;517:81–5.
doi: 10.1016/j.cca.2021.02.015
pubmed: 33647266
Wu L, Wu Q, Li Q, Cao S, Zhang Y, Liu Y, et al. Consecutive reference intervals for biochemical indices related to serum lipid levels and renal function during normal pregnancy. BMC Pregnancy Childbirth. 2022;22:642.
doi: 10.1186/s12884-022-04960-0
pubmed: 35971117
pmcid: 9377122
Yuan X, Zhou L, Zhang B, Wang H, Jiang J, Yu B. Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy Complications. Clin Biochem. 2019;71:46–51.
doi: 10.1016/j.clinbiochem.2019.07.001
pubmed: 31278894
Yuan X, Long W, Liu J, Zhang B, Zhou W, Jiang J, et al. Associations of serum markers screening for Down’s syndrome with pregnancy outcomes: a Chinese retrospective cohort study. Clin Chim Acta. 2019;489:130–5.
doi: 10.1016/j.cca.2018.12.001
pubmed: 30529497
Yuan X, Hu H, Zhang M, Long W, Liu J, Jiang J, et al. Iron Deficiency in late pregnancy and its associations with birth outcomes in Chinese pregnant women: a retrospective cohort study. Nutr Metab (Lond). 2019;16:30.
doi: 10.1186/s12986-019-0360-9
pubmed: 31080491
Farias DR, Franco-Sena AB, Vilela A, Lepsch J, Mendes RH, Kac G. Lipid changes throughout pregnancy according to pre-pregnancy BMI: results from a prospective cohort. BJOG. 2016;123:570–8.
doi: 10.1111/1471-0528.13293
pubmed: 25639335
Roland MCP, Lekva T, Godang K, Bollerslev J, Henriksen T. Changes in maternal blood glucose and lipid concentrations during pregnancy differ by maternal body mass index and are related to birthweight: a prospective, longitudinal study of healthy pregnancies. PLoS ONE. 2020;15:e0232749.
doi: 10.1371/journal.pone.0232749
pubmed: 32574162
pmcid: 7310681
Rao C, Ping F. Second-trimester maternal lipid profiles rather than glucose levels predict the occurrence of neonatal macrosomia regardless of glucose tolerance status: a matched cohort study in Beijing. J Diabetes Complications. 2021;35:107948.
doi: 10.1016/j.jdiacomp.2021.107948
pubmed: 34024685
Vrijkotte TG, Algera SJ, Brouwer IA, van Eijsden M, Twickler MB. Maternal triglyceride levels during early pregnancy are associated with birth weight and postnatal growth. J Pediatr. 2011;159:736–42e1.
doi: 10.1016/j.jpeds.2011.05.001
pubmed: 21705016
Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. Maternal lipid profile during early pregnancy and pregnancy Complications and outcomes: the ABCD study. J Clin Endocrinol Metab. 2012;97:3917–25.
doi: 10.1210/jc.2012-1295
pubmed: 22933545
Liu B, Geng H, Yang J, Zhang Y, Deng L, Chen W, et al. Early pregnancy fasting plasma glucose and lipid concentrations in pregnancy and association to offspring size: a retrospective cohort study. BMC Pregnancy Childbirth. 2016;16:56.
doi: 10.1186/s12884-016-0846-7
pubmed: 26988100
pmcid: 4794833
Adank MC, Benschop L, Kors AW, Peterbroers KR, Smak Gregoor AM, Mulder MT, et al. Maternal lipid profile in early pregnancy is associated with foetal growth and the risk of a child born large-for-gestational age: a population-based prospective cohort study: maternal lipid profile in early pregnancy and foetal growth. BMC Med. 2020;18:276.
doi: 10.1186/s12916-020-01730-7
pubmed: 33004027
pmcid: 7532083
Misra VK, Trudeau S, Perni U. Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obes (Silver Spring). 2011;19:1476–81.
doi: 10.1038/oby.2011.43
Kulkarni SR, Kumaran K, Rao SR, Chougule SD, Deokar TM, Bhalerao AJ, et al. Maternal lipids are as important as glucose for fetal growth: findings from the Pune Maternal Nutrition Study. Diabetes Care. 2013;36:2706–13.
doi: 10.2337/dc12-2445
pubmed: 23757425
pmcid: 3747887
Mossayebi E, Arab Z, Rahmaniyan M, Almassinokiani F, Kabir A. Prediction of neonates’ macrosomia with maternal lipid profile of healthy mothers. Pediatr Neonatol. 2014;55:28–34.
doi: 10.1016/j.pedneo.2013.05.006
pubmed: 23911877
Hou RL, Zhou HH, Chen XY, Wang XM, Shao J, Zhao ZY. Effect of maternal lipid profile, C-peptide, insulin, and HBA1c levels during late pregnancy on large-for-gestational age newborns. World J Pediatr. 2014;10:175–81.
doi: 10.1007/s12519-014-0488-7
pubmed: 24801236
Wang X, Guan Q, Zhao J, Yang F, Yuan Z, Yin Y, et al. Association of maternal serum lipids at late gestation with the risk of neonatal macrosomia in women without Diabetes Mellitus. Lipids Health Dis. 2018;17:78.
doi: 10.1186/s12944-018-0707-7
pubmed: 29642923
pmcid: 5896067
Woollett LA, Urbina EM, Woo JG. Longitudinal changes in HDL-cholesterol concentration are associated with different risk factors in primiparous and nulliparous young women: the NHLBI Growth and Health Study (NGHS). J Clin Lipidol. 2021;15:488–99.
doi: 10.1016/j.jacl.2021.03.004
pubmed: 33875403
pmcid: 8771461
Li C, Su YF, Jin L, Guo YY, Ding GL, Tang L, et al. Association between higher levels of serum estradiol and elevated levels of fibrin (fibrinogen) degradation products in late pregnancy following assisted reproductive technology treatment. Thromb Res. 2020;187:63–71.
doi: 10.1016/j.thromres.2019.12.024
pubmed: 31958688